| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.37 | 0.01 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.41 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |